Entera Bio Ltd.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$8,889,000 over the previous period. Total operating expenses were $8,860,000.

Profit Margin

Entera Bio Ltd. (NASDAQ:ENTX): Profit margin
2015 0 -4.28M
2016 0 -1.19M
2017 0 -11.19M
2018 500K -10.30M -2060.8%
2019 236K -10.87M -4609.75%
2020 365K -9.98M -2735.07%
2021 571K -12.18M -2134.33%
2022 134K -13.07M -9754.48%
2023 0 -8.88M

ENTX Income Statement (2015 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
0134K571K365K236K500K000
Cost of revenue
56K101K373K209K210K043K028K
Gross profit
-56K33K198K156K26K500K-43K0-28K
Operating exp.
Research and development
4.51M5.84M6.77M6.39M7.19M8.51M2.76M2.64M2.11M
Selling and marketing
000000000
Total operating expenses
8.86M13.05M12.41M11.28M11.48M11.36M11.34M5.36M3.70M
Operating income
-8.89M-13.01M-12.21M-11.13M-11.45M-10.86M11.34M-5.36M-3.70M
Other income (expenses), net
31K83K-29K-28K659K523K146K4.16M-581K
Income before tax
-8.86M-12.93M-12.24M-9.96M-10.79M-10.30M-11.19M-1.19M-4.28M
Income tax expense
29K137K-59K20K84K557K-146K00
Net income
-8.88M-13.07M-12.18M-9.98M-10.87M-10.30M-11.19M-1.19M-4.28M
Earnings per share
Basic EPS
-0.31-0.45-0.47-0.54-0.9-1.3-1.31-0.14-0.36
Diluted EPS
-0.31-0.45-0.47-0.54-0.9-1.29-0.94-0.1-0.36
Data sourceData sourceData sourceData sourceData sourceData source